AI Healthcare, Medical Devices Shine In Korea Q1 Financings

Signs Of VC Recovery

 
• By Jung Won Shin

After the financing draught suffered by Korean bioventures in 2023, it now seems the VC market is poised for a recovery as investors shift attention again to the healthcare sector, with a spotlight on AI-based solutions and device firms.

financing recovery
Korean Biopharma financing recovering but IPOs Still struggling • Source: Shutterstock

More from South Korea

More from Focus On Asia